These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 27752938)

  • 1. Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis.
    Menke RA; Agosta F; Grosskreutz J; Filippi M; Turner MR
    Neurotherapeutics; 2017 Jan; 14(1):11-23. PubMed ID: 27752938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of structural and functional brain changes in amyotrophic lateral sclerosis.
    Dharmadasa T; Huynh W; Tsugawa J; Shimatani Y; Ma Y; Kiernan MC
    Expert Rev Neurother; 2018 May; 18(5):407-419. PubMed ID: 29667443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses.
    Agosta F; Spinelli EG; Filippi M
    Expert Rev Neurother; 2018 May; 18(5):395-406. PubMed ID: 29630421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A prognostic biomarker in amyotrophic lateral sclerosis].
    Mitsumoto H; Saito T
    Rinsho Shinkeigaku; 2018 Dec; 58(12):729-736. PubMed ID: 30487362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review.
    Grolez G; Moreau C; Danel-Brunaud V; Delmaire C; Lopes R; Pradat PF; El Mendili MM; Defebvre L; Devos D
    BMC Neurol; 2016 Aug; 16(1):155. PubMed ID: 27567641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroimaging to investigate multisystem involvement and provide biomarkers in amyotrophic lateral sclerosis.
    Pradat PF; El Mendili MM
    Biomed Res Int; 2014; 2014():467560. PubMed ID: 24949452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated magnetic resonance imaging and [
    Alshikho MJ; Zürcher NR; Loggia ML; Cernasov P; Reynolds B; Pijanowski O; Chonde DB; Izquierdo Garcia D; Mainero C; Catana C; Chan J; Babu S; Paganoni S; Hooker JM; Atassi N
    Ann Neurol; 2018 Jun; 83(6):1186-1197. PubMed ID: 29740862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated imaging of [
    Ratai EM; Alshikho MJ; Zürcher NR; Loggia ML; Cebulla CL; Cernasov P; Reynolds B; Fish J; Seth R; Babu S; Paganoni S; Hooker JM; Atassi N
    Neuroimage Clin; 2018; 20():357-364. PubMed ID: 30112276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging in amyotrophic lateral sclerosis: MRI and PET.
    Kassubek J; Pagani M
    Curr Opin Neurol; 2019 Oct; 32(5):740-746. PubMed ID: 31335337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging immunological processes from blood to brain in amyotrophic lateral sclerosis.
    Amor S; Nutma E; Marzin M; Puentes F
    Clin Exp Immunol; 2021 Dec; 206(3):301-313. PubMed ID: 34510431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study.
    Bede P; Chipika RH; Finegan E; Li Hi Shing S; Doherty MA; Hengeveld JC; Vajda A; Hutchinson S; Donaghy C; McLaughlin RL; Hardiman O
    Neuroimage Clin; 2019; 24():102054. PubMed ID: 31711033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis.
    Steinbach R; Batyrbekova M; Gaur N; Voss A; Stubendorff B; Mayer TE; Gaser C; Witte OW; Prell T; Grosskreutz J
    Neuroimage Clin; 2020; 25():102094. PubMed ID: 31896467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resting state functional MRI brain signatures of fast disease progression in amyotrophic lateral sclerosis: a retrospective study.
    Trojsi F; Di Nardo F; Siciliano M; Caiazzo G; Passaniti C; D'Alvano G; Ricciardi D; Russo A; Bisecco A; Lavorgna L; Bonavita S; Cirillo M; Esposito F; Tedeschi G
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Feb; 22(1-2):117-126. PubMed ID: 32885698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis.
    Douaud G; Filippini N; Knight S; Talbot K; Turner MR
    Brain; 2011 Dec; 134(Pt 12):3470-9. PubMed ID: 22075069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interhemispheric connectivity in amyotrophic lateral sclerosis: A near-infrared spectroscopy and diffusion tensor imaging study.
    Kopitzki K; Oldag A; Sweeney-Reed CM; Machts J; Veit M; Kaufmann J; Hinrichs H; Heinze HJ; Kollewe K; Petri S; Mohammadi B; Dengler R; Kupsch AR; Vielhaber S
    Neuroimage Clin; 2016; 12():666-672. PubMed ID: 27761397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Two Clinical Upper Motor Neuron Burden Rating Scales in ALS Using Quantitative Brain Imaging.
    Makary MM; Weerasekara A; Rodham H; Hightower BG; Tseng CJ; Chan J; Chew S; Paganoni S; Ratai EM; Zürcher NR; Hooker JM; Atassi N; Babu S
    ACS Chem Neurosci; 2021 Mar; 12(5):906-916. PubMed ID: 33576234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective harmonized multicenter DTI study of cerebral white matter degeneration in ALS.
    Kalra S; Müller HP; Ishaque A; Zinman L; Korngut L; Genge A; Beaulieu C; Frayne R; Graham SJ; Kassubek J
    Neurology; 2020 Aug; 95(8):e943-e952. PubMed ID: 32646955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis.
    Van Weehaeghe D; Ceccarini J; Delva A; Robberecht W; Van Damme P; Van Laere K
    J Nucl Med; 2016 Aug; 57(8):1238-43. PubMed ID: 26940764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion tensor imaging in sporadic and familial (D90A SOD1) forms of amyotrophic lateral sclerosis.
    Stanton BR; Shinhmar D; Turner MR; Williams VC; Williams SC; Blain CR; Giampietro VP; Catani M; Leigh PN; Andersen PM; Simmons A
    Arch Neurol; 2009 Jan; 66(1):109-15. PubMed ID: 19139308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion kurtosis and quantitative susceptibility mapping MRI are sensitive to structural abnormalities in amyotrophic lateral sclerosis.
    Welton T; Maller JJ; Lebel RM; Tan ET; Rowe DB; Grieve SM
    Neuroimage Clin; 2019; 24():101953. PubMed ID: 31357149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.